PortfoliosLab logo
ResMed Inc. (RMD)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US7611521078

CUSIP

761152107

IPO Date

Jun 2, 1995

Highlights

Market Cap

$34.62B

EPS (TTM)

$8.92

PE Ratio

26.44

PEG Ratio

1.40

Total Revenue (TTM)

$5.02B

Gross Profit (TTM)

$2.94B

EBITDA (TTM)

$1.65B

Year Range

$178.21 - $262.46

Target Price

$263.15

Short %

6.97%

Short Ratio

9.45

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in ResMed Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


0.00%10,000.00%20,000.00%30,000.00%40,000.00%50,000.00%NovemberDecember2025FebruaryMarchApril
41,864.06%
937.58%
RMD (ResMed Inc.)
Benchmark (^GSPC)

Returns By Period

ResMed Inc. had a return of 3.38% year-to-date (YTD) and 9.15% in the last 12 months. Over the past 10 years, ResMed Inc. had an annualized return of 15.42%, outperforming the S&P 500 benchmark which had an annualized return of 10.15%.


RMD

YTD

3.38%

1M

5.96%

6M

-7.48%

1Y

9.15%

5Y*

8.65%

10Y*

15.42%

^GSPC (Benchmark)

YTD

-6.06%

1M

-2.95%

6M

-4.87%

1Y

8.34%

5Y*

13.98%

10Y*

10.15%

*Annualized

Monthly Returns

The table below presents the monthly returns of RMD, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20253.28%-0.90%-4.14%5.37%3.38%
202410.57%-8.43%13.99%8.06%-3.37%-7.23%11.40%15.17%-0.37%-0.68%2.92%-8.16%34.18%
20239.72%-6.55%2.81%10.03%-12.35%3.66%1.76%-28.04%-7.34%-4.50%12.05%9.06%-16.55%
2022-12.24%8.13%-1.72%-17.54%1.96%3.03%14.74%-8.39%-0.74%2.47%3.12%-9.59%-19.47%
2021-5.17%-4.17%0.64%-3.12%9.73%19.76%10.25%7.05%-9.29%-0.24%-2.91%2.21%23.41%
20202.58%0.22%-7.34%5.45%3.78%19.39%5.47%-10.54%-5.17%11.96%9.39%1.41%38.33%
2019-16.42%8.05%1.50%0.52%9.56%6.93%5.47%8.55%-3.01%9.48%1.41%3.59%37.85%
201819.01%-5.13%3.36%-3.89%9.02%0.75%2.12%5.68%3.53%-8.17%5.92%1.86%36.38%
20178.85%7.16%-0.08%-5.53%5.08%9.52%-0.96%1.08%-0.80%9.38%1.88%-0.83%39.06%
20165.61%0.90%1.60%-3.49%6.39%7.06%8.94%-2.72%-2.85%-7.75%3.45%0.93%18.01%
201511.43%3.48%11.53%-10.92%-7.55%-4.17%2.80%-9.88%-1.89%13.05%3.95%-9.87%-2.29%
2014-7.37%1.49%1.52%11.55%0.93%1.14%2.19%3.09%-7.13%5.99%2.43%5.38%21.63%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

With an overall rank of 79, RMD is among the top 21% of stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of RMD is 7979
Overall Rank
The Sharpe Ratio Rank of RMD is 7979
Sharpe Ratio Rank
The Sortino Ratio Rank of RMD is 7575
Sortino Ratio Rank
The Omega Ratio Rank of RMD is 7676
Omega Ratio Rank
The Calmar Ratio Rank of RMD is 8181
Calmar Ratio Rank
The Martin Ratio Rank of RMD is 8282
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for ResMed Inc. (RMD) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


The chart of Sharpe ratio for RMD, currently valued at 0.75, compared to the broader market-2.00-1.000.001.002.003.00
RMD: 0.75
^GSPC: 0.46
The chart of Sortino ratio for RMD, currently valued at 1.35, compared to the broader market-6.00-4.00-2.000.002.004.00
RMD: 1.35
^GSPC: 0.77
The chart of Omega ratio for RMD, currently valued at 1.19, compared to the broader market0.501.001.502.00
RMD: 1.19
^GSPC: 1.11
The chart of Calmar ratio for RMD, currently valued at 0.78, compared to the broader market0.001.002.003.004.005.00
RMD: 0.78
^GSPC: 0.47
The chart of Martin ratio for RMD, currently valued at 3.58, compared to the broader market-5.000.005.0010.0015.0020.00
RMD: 3.58
^GSPC: 1.94

The current ResMed Inc. Sharpe ratio is 0.75. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of ResMed Inc. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio0.001.002.003.00NovemberDecember2025FebruaryMarchApril
0.75
0.46
RMD (ResMed Inc.)
Benchmark (^GSPC)

Dividends

Dividend History

ResMed Inc. provided a 0.88% dividend yield over the last twelve months, with an annual payout of $2.07 per share. The company has been increasing its dividends for 12 consecutive years.


1.00%1.50%2.00%$0.00$0.50$1.00$1.50$2.0020142015201620172018201920202021202220232024
Dividends
Dividend Yield
PeriodTTM20242023202220212020201920182017201620152014
Dividend$2.07$2.02$1.84$1.72$1.62$1.56$1.52$1.44$1.36$1.26$1.16$1.06

Dividend yield

0.88%0.88%1.07%0.83%0.62%0.73%0.98%1.26%1.61%2.03%2.16%1.89%

Monthly Dividends

The table displays the monthly dividend distributions for ResMed Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025$0.00$0.53$0.00$0.00$0.53
2024$0.00$0.48$0.00$0.00$0.48$0.00$0.00$0.53$0.00$0.00$0.53$0.00$2.02
2023$0.00$0.44$0.00$0.00$0.44$0.00$0.00$0.48$0.00$0.00$0.48$0.00$1.84
2022$0.00$0.42$0.00$0.00$0.42$0.00$0.00$0.44$0.00$0.00$0.44$0.00$1.72
2021$0.00$0.39$0.00$0.00$0.39$0.00$0.00$0.42$0.00$0.00$0.42$0.00$1.62
2020$0.00$0.39$0.00$0.00$0.39$0.00$0.00$0.39$0.00$0.00$0.39$0.00$1.56
2019$0.00$0.37$0.00$0.00$0.37$0.00$0.00$0.39$0.00$0.00$0.39$0.00$1.52
2018$0.00$0.35$0.00$0.00$0.35$0.00$0.00$0.37$0.00$0.00$0.37$0.00$1.44
2017$0.00$0.33$0.00$0.00$0.33$0.00$0.00$0.35$0.00$0.00$0.35$0.00$1.36
2016$0.00$0.30$0.00$0.00$0.30$0.00$0.00$0.33$0.00$0.00$0.33$0.00$1.26
2015$0.00$0.28$0.00$0.00$0.28$0.00$0.00$0.30$0.00$0.00$0.30$0.00$1.16
2014$0.25$0.00$0.00$0.25$0.00$0.00$0.28$0.00$0.00$0.28$0.00$1.06

Dividend Yield & Payout


Dividend Yield
5.0%10.0%15.0%20.0%25.0%
RMD: 0.9%
ResMed Inc. has a dividend yield of 0.88%, which signifies it pays a smaller percentage of its stock price in dividends to its shareholders compared to other companies in the market.
Payout Ratio
200.0%400.0%600.0%800.0%1,000.0%1,200.0%
RMD: 18.5%
ResMed Inc. has a payout ratio of 18.47%, which is below the market average. This means ResMed Inc. returns a smaller proportion of its earnings to shareholders as dividends, suggesting it retains a higher portion for reinvestment, growth, or debt payment.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-30.00%-25.00%-20.00%-15.00%-10.00%-5.00%0.00%NovemberDecember2025FebruaryMarchApril
-18.21%
-10.07%
RMD (ResMed Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the ResMed Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the ResMed Inc. was 61.60%, occurring on Apr 8, 1999. Recovery took 200 trading sessions.

The current ResMed Inc. drawdown is 18.21%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-61.6%Jan 26, 199951Apr 8, 1999200Jan 21, 2000251
-60%Dec 4, 2001127Jun 6, 2002726Apr 25, 2005853
-53.99%Sep 9, 2021538Oct 27, 2023
-45.02%Feb 5, 2007437Oct 27, 2008321Feb 5, 2010758
-44.48%Mar 23, 200046May 26, 2000146Dec 22, 2000192

Volatility

Volatility Chart

The current ResMed Inc. volatility is 14.81%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%14.00%NovemberDecember2025FebruaryMarchApril
14.81%
14.23%
RMD (ResMed Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of ResMed Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how ResMed Inc. is priced in the market compared to other companies in the Medical Instruments & Supplies industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio
20.040.060.080.0100.0
RMD: 26.4
The chart displays the Price-to-Earnings (P/E) ratio for RMD, comparing it with other companies in the Medical Instruments & Supplies industry. Currently, RMD has a P/E ratio of 26.4. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PEG Ratio
2.04.06.08.010.0
RMD: 1.4
The chart shows the Price/Earnings to Growth (PEG) ratio for RMD compared to other companies in the Medical Instruments & Supplies industry. RMD currently has a PEG ratio of 1.4. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.
PS Ratio
2.04.06.08.010.0
RMD: 6.9
This chart shows the Price-to-Sales (P/S) ratio for RMD relative to other companies in the Medical Instruments & Supplies industry. Currently, RMD has a P/S ratio of 6.9. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
PB Ratio
2.04.06.08.010.0
RMD: 6.2
The chart illustrates the Price-to-Book (P/B) ratio for RMD in comparison with other companies in the Medical Instruments & Supplies industry. Currently, RMD has a P/B value of 6.2. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items